Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOS3 | P29474 | 1/20 | 0.57 |
| ▸ | NOS1 | P29475 | 1/20 | 0.57 |
| ▸ | NOS2 | P35228 | 1/20 | 0.57 |
| ▸ | HDAC1 | Q13547 | 6/20 | 0.51 |
| ▸ | HDAC6 | Q9UBN7 | 6/20 | 0.51 |
| ▸ | HDAC3 | O15379 | 4/20 | 0.51 |
| ▸ | HDAC4 | P56524 | 4/20 | 0.51 |
| ▸ | HDAC7 | Q8WUI4 | 4/20 | 0.51 |
| ▸ | HDAC2 | Q92769 | 4/20 | 0.51 |
| ▸ | HDAC10 | Q969S8 | 4/20 | 0.51 |
| ▸ | HDAC11 | Q96DB2 | 4/20 | 0.51 |
| ▸ | HDAC8 | Q9BY41 | 4/20 | 0.51 |
| ▸ | HDAC9 | Q9UKV0 | 4/20 | 0.51 |
| ▸ | HDAC5 | Q9UQL6 | 4/20 | 0.51 |
| ▸ | PPARA | Q07869 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | SLC7A5 | Q01650 | 4/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29551005 | 1.00 | NOS3 (0.57) | NOS3NOS1NOS2HDAC1HDAC6 | |
| SCHEMBL29550721 | 1.00 | NOS3 (0.57) | NOS3NOS1NOS2HDAC1HDAC6 | |
| SCHEMBL22689821 | 1.00 | NOS3 (0.57) | NOS3NOS1NOS2HDAC1HDAC6 | |
| SCHEMBL22689688 | 1.00 | NOS3 (0.57) | NOS3NOS1NOS2HDAC1HDAC6 | |
| SCHEMBL22689718 | 1.00 | NOS3 (0.57) | NOS3NOS1NOS2HDAC1HDAC6 | |
| SCHEMBL22689800 | 1.00 | NOS3 (0.57) | NOS3NOS1NOS2HDAC1HDAC6 | |
| SCHEMBL22689720 | 1.00 | NOS3 (0.57) | NOS3NOS1NOS2HDAC1HDAC6 | |
| SCHEMBL22689819 | 1.00 | NOS3 (0.57) | NOS3NOS1NOS2HDAC1HDAC6 | |
| SCHEMBL22689799 | 1.00 | NOS3 (0.57) | NOS3NOS1NOS2HDAC1HDAC6 | |
| SCHEMBL22691458 | 0.99 | NOS3 (0.58) | NOS3NOS1NOS2HDAC1HDAC6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12460317-B2 | Genetically encoded, phage-displayed cyclic peptide library and methods of making the same | THE TEXAS A&M UNIVERSITY SYSTEM (US) | 2025-11-04 | — | — | US | disclosed |
| US-20230139680-A1 | A GENETICALLY ENCODED, PHAGE-DISPLAYED CYCLIC PEPTIDE LIBRARY AND METHODS OF MAKING THE SAME | THE TEXAS A&M UNIVERSITY SYSTEM (US) | 2023-05-04 | — | — | US | disclosed |
| EP-3972625-A1 | A GENETICALLY ENCODED, PHAGE-DISPLAYED CYCLIC PEPTIDE LIBRARY AND METHODS OF MAKING THE SAME | The Texas A&M University System (US) | 2022-03-30 | — | — | EP | disclosed |
| CN-113727725-A | Genetically encoded phage-displayed cyclic peptide libraries and methods of making the same | 得克萨斯A&M大学系统 | 2021-11-30 | — | — | CN | disclosed |
| WO-2020236146-A1 | A GENETICALLY ENCODED, PHAGE-DISPLAYED CYCLIC PEPTIDE LIBRARY AND METHODS OF MAKING THE SAME | THE TEXAS A&M UNIVERSITY SYSTEM (US) | 2020-11-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230139680-A1 | A GENETICALLY ENCODED, PHAGE-DISPLAYED CYCLIC PEPTIDE LIBRARY AND METHODS OF MAKING THE SAME | QPCTL, LNPEP, QPCT | NOS3 2430/4885NOS1 2420/4885NOS2 2097/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.